A better vaccine against Ebola?

Weizmann study may show the way BRIEFS DATE: NOVEMBER 19, 2019 A vaccine that protects against Ebola—one of the world’s deadliest viral diseases—was recently approved by the European Medicines Agency (EMA), the first time any immunization against Ebola has passed this...

Q&A with Prof. Alon Chen

A lively conversation with the Weizmann Institute's incoming President Q&A DATE: OCTOBER 23, 2019 Prof. Alon Chen Prof. Alon Chen enters office as the next President of the Weizmann Institute on December 1. A  world-renowned neuroscientist with a focus on stress,...

Neurobiology News

Three papers by Weizmann Institute of Science neuroscientists are slated to appear in the December issue of Nature Neuroscience. 12.11.2019   Our emotions play a central role in learning and memory, and they enable survival in a dynamic environment. Tamar...

Ebola Antibodies at Work

Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease 07.10.2019 The glycoprotein spike complex of the Ebola virus bound by a neutralizing antibody isolated from a vaccinated...

The Basic Bacterial Defense

A newly-discovered immune system in bacteria is the distance ancestor of one in our own cell 26.09.2019 E coli with and without active CBASS defenses against viral infection. Between 40 min. and and hour, those with active systems (l) committed suicide; while after an...